Von Willebrand Factor’s effects during COVID-19-associated coagulopathy does not appear unique to the virus, but rather to the presence of inflammation, as other conditions such as sepsis, DIC, cancer, and malaria also show marked effects on the von Willebrand Factor. The gene discussed is VWF; the disease is blood coagulation disease.